Globalworld globe
United Kingdom
North America
Europe
  • facebook
  • linkedin
Medical Developments International
  • Home
  • Products
    • Asthma & COPD
    • Penthrox
    • Medical Devices
    • Veterinary
  • About
    • Distributor Information
    • Careers
    • Associations
  • Investors/Media
    • Financial Reports
    • Board of Directors/Management
    • Corporate Governance
    • Media Centre
    • Diversity Policy
    • Share Trading Policy
  • Healthcare Professionals
  • Contact

News

MVP signs Respiratory deals in the United States and Portugal

May 25, 2016Mark EdwardsNews

25 May 2016

ASX ANNOUNCEMENT

MVP signs Respiratory deals in the United States and Portugal

Medical Developments International Limited (ASX: MVP) is delighted to announce that it has signed distribution deals with:

  • AmerisourceBergen for the distribution of its range of ‘Anti-static Compact Space Chamber’ Respiratory Devices in the United States of America (US); and
  • OverPharma Lda. for the exclusive sales and marketing of its range of ‘Anti-static Space Chamber Plus Range’ Respiratory Devices in Portugal.

For more details please click on the following link ASX Announcement – Respiratory update

Contact Us

for information on our range of products

Find a distributor

in our global network

Investors

invest in a company with
innovative foresight

News

  • Green Whistle gets the Green Light – FDA clears US Penthrox clinical trial

    2 March 2022 ASX ANNOUNCE...

  • MVP FY22 Half Year Results Investor Presentation

    25 February 2022 ASX anno...

  • MVP FY22 Half Year Report and Accounts

    24 February 2022 ASX Anno...

Healthcare Professional Registration

Login to access healthcare professional resources



Remember Me

Forgot password? | Register

Medical Developments International

Address:
4 Caribbean Drive, Scoresby,
Victoria, 3179
Australia
Phone: +61 3 9547 1888
Email: [email protected]
ABN: 14 106 340 667
For Medical Enquiries:

Phone: 1800 PENTHROX (1800 736 847)
Email: [email protected]

Email Newsletter